Cover Image

A new EPOR/CD131 heteroreceptor agonist EP-11-1: a neuroprotective effect in experimental traumatic brain injury

Introduction: EP-11-1 (UEHLERALNSS) is a short-chain erythropoietin derivative without have erythropoietic activity. It was created by modifying a peptide mimicking the spatial structure of the erythropoietin a-helix B pHBSP. One of the promising directions of its administration is the correction of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Oleg V. Antsiferov (Author), Roman F. Cherevatenko (Author), Mikhail V. Korokin (Author), Vladimir V. Gureev (Author), Anastasia V. Gureeva (Author), Mariya A. Zatolokina (Author), Elena V. Avdeyeva (Author), Lyudmila A. Zhilinkova (Author), Inga M. Kolesnik (Author)
Format:	Book
Published:	Belgorod National Research University, 2021-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

STUDY OF ANTIATHEROSCLEROTIC AND ENDOTHELIOPROTECTIVE ACTIVITY OF PEPTIDE AGONISTS OF EPOR/CD131 HETERORECEPTOR
by: Olesya A. Puchenkova, et al.
Published: (2020)

Study of the neuroprotective properties of the heteroreceptor EPOR/CD131 agonist of peptide structure in tau-proteinopathy modeling
by: Yulia V. Stepenko, et al.
Published: (2024)

STUDY OF THE PHARMACOLOGICAL ACTIVITY OF NOVEL EPOR/CD131 HETERORECEPTOR AGONISTS IN MICE WITH ENDOTHELIAL-SPECIFIC EXPRESSION OF MUTANT POLG GENE
by: М. В. Korokin, et al.
Published: (2021)

The EPOR/CD131 heteroreceptoragonist has an endothelioprotective effect against the background of pulmonary hypertension caused by monocrotalin
by: Lilia V. Korokina
Published: (2023)

THE SEARCH FOR NEUROPROTECTIVE COMPOUNDS AMONG NEW ETHYLTHIADIAZOLE DERIVATIVES
by: R. F. Cherevatenko, et al.
Published: (2021)

Study of the effect of selective inhibitor of Arginase II KUD 975 and of low doses of Acetylsalicylic acid on the functional parameters of the cardiovascular system In experimental preeclampsia
by: Olga V. Severinova, et al.
Published: (2019)

Influence of silver-ion-containing pharmacotherapeutic system for repair of anterior abdominal wall on connective tissue formation in experiment
by: Ekaterina S. Mishina, et al.
Published: (2019)

Study of the effect of acetylsalicylic acid and a selective arginase II inhibitor KUD 975 on the correction of hemostatic disorders in experimental preeclampsia
by: Anastasia V. Gureeva, et al.
Published: (2022)

Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia
by: Tatyana I. Lokteva, et al.
Published: (2020)

Preclinical study of innovative peptides mimicking the tertiary structure of the α-helix B of erythropoietin
by: Ivan V. Golubev, et al.
Published: (2020)

L-NAME-induced Preeclampsia: correction of functional disorders of the hemostasis system with Resveratrol and Nicorandil
by: Elena G. Stupakova, et al.
Published: (2019)

CORRECTION OF MORPHOFUNCTIONAL DISORDERS IN EXPERIMENTAL PREECLAMPSY BY COMBINED USE OF TRIMETAZIDINE AND PURIFIED MICRONIZED FLAVONOID FRACTION AS WELL AS THEIR COMBINATIONS WITH METHYLAMPSY
by: O. E. Antsiferova, et al.
Published: (2021)

Evaluation of pharmacological correction of L-name-induced endothelial dysfunction, platelet aggregation and venous tone with diosmin Detralex 1000 mg
by: Yulia Lukyanova, et al.
Published: (2018)

Erythropoietin Receptor (EpoR) Agonism Is Used to Treat a Wide Range of Disease
by: Fabian Sanchis-Gomar, et al.
Published: (2013)

Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
by: Gemma Navarro, et al.
Published: (2018)

Transgenic mice Cre-dependently expressing mutant polymerase-gamma: novel test-system for pharmacological study of mitoprotective drugs
by: Marina V. Kubekina, et al.
Published: (2021)

Molecular Integration in Adenosine Heteroreceptor Complexes Through Allosteric and De-Phosphorylation (STEP) Mechanisms and its Role in Brain Disease
by: Dasiel O. Borroto-Escuela, et al.
Published: (2022)

Study of analgesic activity and effects of new dipharmacophores - nebracetam and cyclooxygenase-2 inhibitors derivatives on the cognitive abilities of rats
by: Vitaliy S. Slyusarenko, et al.
Published: (2021)

Mechanism of neuroprotective effect of mGluR4 agonists
by: Natalya V. Avdeeva, et al.
Published: (2019)

Modern neuroprotection in pediatrics
by: M.V. Khaitovych
Published: (2020)

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
by: Zhimin Chen, et al.
Published: (2018)

The Delayed Neuroprotective Effect of Methylene Blue in Experimental Rat Brain Trauma
by: Elizaveta E. Genrikhs, et al.
Published: (2020)

Efficacy of neuroprotective treatment including pyrimidine nucleotides in secondary uveitic glaucoma
by: V. V. Savko, et al.
Published: (2018)

Radioiodination and Purification of [<sup>131</sup>I]β-CIT and [<sup>131</sup>I]FP-CIT with an Automated Radiosynthesizer
by: Elisabeth Plhak, et al.
Published: (2022)

Suppression of NLRP3 Inflammasome by Erythropoietin via the EPOR/JAK2/STAT3 Pathway Contributes to Attenuation of Acute Lung Injury in Mice
by: Fei Cao, et al.
Published: (2020)

Impact of neuroprotective therapy on cognition and oxidative stress in the early stages of Parkinson's disease
by: A. V. Demchenko, et al.
Published: (2021)

Uropathogenic ST131 in urinary tract infections in children
by: Ki Wook Yun, et al.
Published: (2017)

Heterogeneity of EpCAM-positive cells in low-grade serous ovarian carcinoma ascitic fluid: a clinical case
by: E. V. Kaigorodova, et al.
Published: (2022)

Efficacy of complex neuroprotection in glaucomatous optic neuropathy
by: O.V. Guzun, et al.
Published: (2018)

3D organotypic cell structures for drug development and Microorganism-Host interaction research
by: Ekaterina V. Zubareva, et al.
Published: (2021)

Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen<sup>®</sup>, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson's Disease
by: Ana Claudia R. Durante, et al.
Published: (2019)

Exploring the neuroprotective role of probiotics in the therapeutic interventions of cognitive decline
by: J Renukadevi, et al.
Published: (2024)

The Wide World Magazine, Vol. 22, No. 131, February, 1909
by: Various

Health behaviours in 131,182 UK women planning pregnancy
by: Beth McDougall, et al.
Published: (2021)

Development of [131I]I-EOE-TPZ and [131I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia
by: Hassan Elsaidi, et al.
Published: (2019)

Neuroprotective effects of taurine and 3-hydroxypyridine derivatives in the intracerebral hemorrhage model in rats
by: Natalia I. Nesterova, et al.
Published: (2019)

Assessment of the correction of neuroretinal changes using 2-ethyl-6-methyl-3-hydroxypyridinium N-acetyltaurinate in the modeling of POAG
by: Svetlana V. Efimenko, et al.
Published: (2024)

Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment
by: Vladislav Elagin, et al.
Published: (2018)

Therapy preference of 131 parents confronted with a pediatric femoral fracture
by: Christoph Arneitz, et al.
Published: (2022)

Neuroprotective and anticonvulsant effects of Cerebrolysin in the experiment
by: T. E. Bogacheva, et al.
Published: (2017)